Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
In spite of significant progress in disease diagnosis and treatment, racial and ethnic minorities experience lower quality of care and poorer outcomes for certain conditions than non-minorit...
Cancer is a heterogeneous but related group of diseases wherein cells in certain tissues of the body proliferate uncontrollably and eventually invade adjacent and distant tissues. The oldest...
Each year, more monoclonal antibodies (mAbs) are approved by regulatory agencies to treat a wide range of diseases with an expected market value of over $200 billion by 2026. The advantage o...
Date: November 9, 2021 Time: 3:00am (PDT), 6:00am (EDT), 12:00pm (CEST) An increasing number of cervical cancer screening programs are converting from cytology to primary HPV-based organiz...
Date: November 08, 2022 Time: 11:00am (PST), 2:00pm (EST), 8:00pm (CET) Developing safe and effective CAR T cell therapies is a challenging task. That’s why thinking translational earl...
Date: October 27, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) The Problem Buffer exchange is a critical step to developing optimal vectors and payloads. Compared to biologics, deve...
Date: November 08, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) While flow cytometry shines by its flexibility, it requires a high level of expertise in antibody panel development,...
Date: November 8, 2022 Time: 1:00pm (SGT), 12:00pm (EST), 6:00am (CET) Antibodies are vital tools in many of the laboratory techniques that are used...
Date: November 3, 2022 Time: 9:00am (PDT), 11:00pm (EDT), 6:00pm (CEST) Join this webinar to learn more about the new X9™ real-time PCR system from Standard BioTools™. Microflu...
Date: November 3, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) In this webinar, our speakers will provide an introduction into the epidemiology of influenza A/B, RSV, COVID-19, Aden...
Date: October 13, 2022 Time: 10:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Most known immune checkpoints exert their effects upon protein-protein interactions, such as the PD1 checkpoint on CD...
Genome engineers can leverage an ever-expanding array of biological and computational tools to make targeted genetic changes. Maintaining and optimizing components ranging from reagent desig...
As we further understand the complexity and diversity of cellular states, it is becoming necessary for a cellular engineering toolbox, consisting of molecular tools that allow control over c...
Nucleic acid analysis is crucial for the diagnostics of infectious diseases such as COVID-19. CRISPR/Cas technology, beyond its broad application in gene editing, features, in this regard, a...
Clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 13 (Cas13) has been rapidly developed for nucleic-acid-based diagnostics by using its chara...
Date: November 2, 2022 Time: 7:00am (PDT), 10:00pm (EDT), 4:00pm (CEST) As part of the immune response, inflammation plays a vital role in the host defense and is dictated by the balance bet...
My laboratory uses tools from pharmacology, genomics, and cell signaling to study two key aspects of cancer biology. First, we seek to understand how oncogenic signals, altered metabolic sta...
Traditional methods for pathogen detection are often expensive and time-consuming and requires a well-equipped laboratory. Here we present a low-cost, deployable paper-based biosensor device...
The Cas9 from Francisella novicida (FnCas9) has unique properties of target identification and engagement in terms of specificity, nature of double strand break as well as length of guide RN...
Simple and sensitive nucleic acid-based molecular detection plays a crucial role in the early diagnosis of infectious diseases and the rapid screening of cancers. CRISPR technology has recen...
The CRISPR revolution has begun and shows no signs of slowing down. CRISPR-Cas nuclease-based genome editing strategies hold great promise for the treatment of genetic disorders. However, a...
CRISPR has revolutionized the biosciences over the past decade. The RNA-targeting CRISPR effector protein Cas13, discovered in 2016, opened up a myriad of new applications for CRISPR-based t...
The COVID-19 pandemic highlights the need for diagnostics that can be rapidly adapted and deployed in a variety of settings. Several SARS-CoV-2 variants have shown worrisome effects on vacci...
Rapid, accurate and frequent detection of the RNA of SARS-CoV-2 and of serological host antibodies to the virus would facilitate the determination of the immune status of individuals who hav...
The clustered regularly interspaced short palindromic repeat (CRISPR) genome-editing revolution established the beginning of a new era in life sciences. I will report the role of state-of-th...
Cancer, as a disease, starts with a change in the genome that results in the downregulation of genes involved in "normal" cell behavior. This genetic change can either be induced b...
In spite of significant progress in disease diagnosis and treatment, racial and ethnic minorities experience lower quality of care and poorer outcomes for certain conditions than non-minorit...
